Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 350 participants.

Also called NCT07925502

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 350 participants (planned count) (from the registry)
Sponsor
  • Xeltis Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07925502
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07925502. Allocation not applicable; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2030-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit
Acronym
aXess4All
Condition
End Stage Renal Failure, Hemodialysis
Intervention (Device)
Xeltis aXess Hemodialysis Conduit
Lead sponsor
Xeltis (class: industry)

Record details

Record id
cardio:ct-nct07925502
Content hash
a15cbc5d55396379a182ad0a821007e7dcd83a078a6b173fa852c5c6a4d0effe